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ABSTRACT 
 
 Diabetes mellitus (DM) induces bone deterioration, while mechanical stimulation promotes 
osteocyte-driven bone formation. We aimed to evaluate the interaction of acute exposure (24h) to high 
glucose (HG) with both the pro-survival effect conferred to osteocytic MLO-Y4 cells and osteoblastic 
MC3T3-E1 cells by mechanical stimulation and the interaction of these cells with osteoclast precursor 
RAW264.7 cells. We found that 24h of HG (25 mM) pre-exposure prevented both cell survival and ERK and 
β-catenin nuclear translocation upon mechanical stimulation by fluid flow (FF) (10 min) in both MLO-Y4 
and MC3T3-E1 cells. However, migration of RAW 264.7 cells was inhibited by MLO-Y4 cell-conditioned 
medium (CM), but not by MC3T3-E1 cell-CM, with HG or FF. This inhibitory effect was associated with 
consistent changes in VEGF, RANTES, MIP-1α, MIP-1β MCP-1 and GM-CSF in MLO-Y4 cell-CM. 
RAW264.7 proliferation was inhibited by MLO-Y4 CM under static or HG conditions, but itincreased by 
FF-CM with or without HG. In addition, both FF and HG abrogated the capacity of RAW 264.7 cells to 
differentiate into osteoclasts, but in a different manner. Thus, HG-CM in static condition allowed formation 
of osteoclast-like cells, which were unable to resorb hydroxyapatite. In contrast, FF-CM prevented 
osteoclastogenesis even in HG condition. Moreover, HG did not affect basal RANKL or IL-6 secretion or 
their inhibition induced by FF in MLO-Y4 cells. In conclusion, this in vitro study demonstrates that HG 
exerts disparate effects on osteocyte mechanotransduction, and provides a novel mechanism by which DM 
disturbs skeletal metabolism through altered osteocyte-osteoclast communication. This article is protected by 
copyright. All rights reserved  
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INTRODUCTION 
Diabetes mellitus (DM) is a complex disease with deleterious effects on the skeleton. In fact, both 
type 1 (T1D) and type 2(T2D) DM are associated with an increased risk of fractures (Carnevale et al., 2004; 
Yamamoto et al., 2009); although their bone phenotypes are different. Thus, while T2D patients have normal 
or high bone mineral density (BMD), T1D patients have reduced BMD (Hofbauer et al., 2007; Nicodemus 
and Folsom, 2001; Vestergaard, 2007). The underlying mechanisms of bone tissue deterioration and fracture 
risk elevation in DM remain ill- defined. The increase of glucose concentration and advanced glycation end 
products (AGEs) accumulation present in both types of DM are thought to be responsible for at least some of 
the features of diabetic osteopathy, such as the inhibition of proliferation and differentiation of bone cell 
precursors (Botolin and McCabe, 2006; Saito et al., 2006).  
Mechanical force is one of the most important inputs that the skeleton receives to regulate bone 
mass, shape and microarchitecture (Robling and Turner, 2009). The skeleton is able to adapt to an increased 
load by stimulating bone formation, while skeletal disuse leads to an increased bone resorption (Aguirre et 
al., 2006; Bikle et al., 2003; Burr et al., 2002). It is now well established that osteocytes are the main 
mechanosensor cell in bone, regulating both osteoblast and osteoclast function. Osteocytes are long-lived 
cells, trapped in the bone mineralized matrix and exhibiting cytoplasmic processes inside narrow tunnels 
called canaliculi. These cell dendrites define an extensive and complex network, which allows an effective 
communication not only between neighbor osteocytes but also between osteocytes and osteoblasts and 
osteoclasts located on the bone surface. This strategic position in the bone mineralized matrix and the 
complexity of the osteocyte process network allows osteocytes to sense changes in bone load, sending 
signals to osteoblasts and osteoclasts to form or resorb bone (Bellido, 2014; Maycas et al, 2016). Osteocytes 
are able to control osteoblast function by producing sclerostin, encoded by the SOST gene, which inhibits 
osteoblast activity through antagonizing the Wnt/β-catenin pathway (Kamiya et al., 2008; Poole et al., 2005). 
In addition, osteocytes produce the receptor activator of nuclear factor κB ligand (RANKL) that supports 
osteoclast differentiation and activity (Nakashima et al., 2011). Lack of mechanical forces induces osteocyte 
apoptosis, and this event is related to the recruitment and differentiation of osteoclast precursors. In the 
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absence of mechanical stimulation, osteocytes also produce osteoclast signals to stimulate bone resorption 
(Aguirre et al., 2006; Plotkin et al., 2015). Factors involved in angiogenesis and osteoclast function, such as 
vascular endothelial growth factor (VEGF) and RANKL, respectively, are known to increase in live 
osteocytes located close to apoptotic osteocytes, but the underlying mechanisms targeting bone resorption at 
specific bone sites are still ill-defined (Kennedy et al., 2012).Chemokines are a family of cytokines that 
provide key signals for recruiting different subpopulations of leukocytes and other cell types in both 
physiological and pathological situations (Bryant et al, 2015). Some chemokines are expressed by bone cells 
and could be involved in osteoclast recruitment (Lin et al, 2014; Yu et al, 2004). 
 
Of interest, it has been recently shown that a diabetic environment hampers some downstream 
responses to mechanical stimulation both in vivo and in vitro (Parajuli et al., 2015). Therefore, in the present 
study, we hypothesized that a high glucose (HG) environment might interact with mechanotransduction in 
MLO-Y4 osteocytes and subsequently with osteoclast recruitment, differentiation and activity, using murine 
RAW 264.7 monocytic cells as osteoclast precursors. 
 
MATERIALS AND METHODS 
Cell cultures: The osteocytic MLO-Y4 cell line, derived from murine long bones(Kato et al., 1997) 
and MLO-Y4 nuclear-GFP cells, stably transfected with nuclear green fluorescent protein (nGFP) (Plotkin et 
al., 1999),were grown in α-MEM supplemented with 2.5% fetal bovine serum (FBS), 2.5% calf serum (CS) 
and 1% penicillin-streptomycin in 5% CO2 at 37 ºC. Mouse pre-osteoblastic MC3T3-E1 cells (CRL-2593; 
American Type Culture Collection, Mannasas, VA, USA) were grown in α-MEM supplemented with 10% 
FBS, 1% penicillin-streptomycin and 2 mM glutamine in 5% CO2at 37 ºC. Murine RAW 264.7 macrophages 
(Suzuki et al., 2008) were grown in α-MEM supplemented with 10% FBS and 1% penicillin-streptomycin in 
5% CO2 at 37 ºC. Both MLO-Y4 and MC3T3-E1 cells were plated at 2x10
4 
cells/cm
2
 on collagen-coated 
glass slides (FlexCell, Hillsborough, NC, USA); the next day, fresh medium with high D-glucose (HG) (the 
α-MEM medium -containing 5.5 mM of D-glucose- was supplemented with the necessary amount of D-
glucose to reach a final concentration of 25 mM,) (or high L-glucose as osmotic  control) or normal glucose  
(NG) (5.5 mM) was added for 24 h.  Then, cells were submitted or not (static control, SC) to mechanical 
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stress by laminar fluid flow (FF) with a shear stress of 10 dynes/cm2, 8 Hz, for 10 min in a Flexcell® 
Streamer® shear stress device. The media flowed over the cells was consistently serum-depleted α-MEM in 
every experimental condition. The concentration used for HG (25 mM) is equivalent to 450 mg/dl a widely 
used concentration in studies mimicking the diabetic milieu in bonecells (Lozano et al, 2009; Parajuli et al, 
2015). The magnitude of the predicted fluid flow-induced shear stress in physiological conditions in 
osteocytes is estimated to be in the range of 8-30 dynes/cm2. Thus, the regimen used in our study lies within 
the frame of physiological relevance (Sorkin et al, 2004; Weinbaum et al, 1994).  Thereafter, different 
protocols were carried out depending on the endpoint studied. Thus, for Western blot analysis, protein 
extracts were obtained immediately after FF. For apoptosis determination, cells were exposed to a pro-
apoptotic agent (see below) for an additional 6h.Cells were cultured with fresh medium (α-MEM without 
serum) for an additional 18 h after FF (or SC) to collect the cell-conditioned medium (CM) in the different 
experimental groups: CM from SC cells in NG medium; CM from FF-stimulated cells in NG medium; CM 
from SC cells pre-treated with either HG or L-glucose-containing medium; CM from FF-stimulated cells 
pre-cultured in HG medium. 
Apoptosis and cell viability determination: Following FF, MLO-Y4 nuclear-GFP or MC3T3-E1 cells 
were exposed to the well characterized pro-apoptotic agent etoposide (50 µM) in FBS-depleted medium for 6 
h and subsequently were fixed with neutral buffered formalin. Apoptosis was assessed by enumerating nGFP 
positive MLO-Y4 cells exhibiting chromatin condensation and nuclear fragmentation under a fluorescence 
microscope, as previously reported (Plotkin et al., 1999). For MC3T3-E1 cell death determination, non-
adherent cells were collected and pooled with adherent cells (after gentle trypsinization). Cell death was 
determined by trypan blue exclusion, calculating the percent of nonviable cells -exhibiting intracellular 
staining- per total cell number. 
Western blot analysis: Total cell protein was extracted with 50 mMTris–HCl, pH 7.4, 150 mMNaCl, 
1mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, and 0.1% sodium dodecyl sulfate (SDS), 
supplemented with protease inhibitor cocktail P8340 (Sigma-Aldrich, St. Louis, MO, USA) and phosphatase 
inhibitor cocktail Set II (Calbiochem, San Diego, CA, USA). Nuclear protein extracts were obtained by using 
the “Subcellular protein fractionation kit” (Pierce, Rockford, IL, USA), according to the manufacturer’s 
instructions. Protein content was determined by BCA Protein Assay (Thermo Fisher Scientific, Rockford, IL, 
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USA) using bovine serum albumin (BSA) as standard. Protein extracts (25-30 μg) were separated on 10 % 
polyacrylamide gels in reducing conditions, followed by transfer to nitrocellulose membranes (GE-
Amersham, Buckinghamshire, UK). Blots were blocked with 2.5% defatted milk in 0.1% Tween-Tris 
buffered saline (TBS) or with 5% BSA in 0.1% Tween-TBS, pH 7.4, at room temperature for 1 h, and then 
probed overnight at 4ºC with the following rabbit polyclonal antibodies: p-GSK3β(Ser9) (Cell Signalling, 
Beverly, MA, USA) (at 1:500 dilution), β-catenin antibody (Abcam, Cambridge, MA, USA) (at 1:4000 
dilution), p-ERK1/2 (Thr202/Tyr204) and ERK1/2 antibody (Cell Signalling) (each at 1:1000 dilution); and 
the mouse monoclonal antibody GSK3β (Cell Signalling). For loading controls, mouse monoclonal anti-α-
tubulin antibody (Sigma-Aldrich) and rabbit polyclonal lamin B1 antibody (Abcam) were used where 
appropriate. After incubation with the corresponding secondary horseradish peroxidase-coupled IgG (Santa 
Cruz Biotechnology), blots were developed with ECL system (GE-Amersham), and band intensities were 
quantified by densitometry. 
Cytokine determination: Thechemokinesgranulocyte macrophage colony-stimulated factor (GM-CSF), 
monocyte chemotactic protein (MCP)-1, macrophage inflammatory protein (MIP)-1α, MIP-1β, regulated on 
activation, normal T cell expressed and secreted (RANTES), and VEGF, were evaluated in MLO-Y4 cell-
CM using the Milliplex system (Merck Millipore, St. Charles, MO, USA) on the Bio-Plex platform (Bio-Rad 
Laboratories, Hercules, CA, USA). RANKL and IL-6 were evaluated in MLO-Y4 cell-CM using specific 
mouse ELISA Kits from Abcam and Gen-Probe (Diaclone, Besancon, France), respectively, according to the 
corresponding manufacturer’s instructions. The sensitivity of the assays was 10.9 pg/ml for GM-CSF, 6.7 
pg/ml for MCP-1, 7.7 pg/ml for MIP-1α, 11.9 pg/ml forMIP-1β, 2.7 pg/ml for RANTES, 0.3 pg/ml for 
VEGF, 4 pg/ml for RANKL and 10 pg/ml for IL-6 and their inter assay variation coefficient was <12 %. 
Transwell migration assay: Migration assay was performed using Costar transwell cell culture 
chamber inserts (Corning Costar Corporation, Cambridge, MA) with an 8 μm pore size. Briefly, 5 × 104 
RAW 264.7 cells were placed in the upper chamber in 100 μL of serum-freestandard medium containing 
20% of each MLO-Y4 (A) or MC3T3-E1 (B) cell-conditioned medium for 6 h. Then, the medium and the 
upper cell layer were removed with the aid of a cotton swab, and cells on the underside of the transwell were 
fixed, stained with crystal violet and counted in five randomly selected fields at 200× magnification using the 
phase contrast microscope. 
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Wound healing assay: RAW 264.7 cells (5 × 10
4 
/cm
2
) were seeded on 6-well plates in α-MEM 
supplemented with 10% FBS. The day after, a scratch was made across the RAW 264.7 cell layer using a 
sterile pipette tip. Cells were then washed with phosphate-buffered saline (PBS) and the medium was 
replaced by serum-free standard medium containing 20% of each MLO-Y4 cell-CM for 6 h. Cells were 
thereafter cultured for 8 h to allow cell migration, and migrated cells into the scratch were counted at 200x 
magnification using a Leica DM6000 phase contrast microscope. 
Osteoclast differentiation on hydroxyapatite disks: RAW-264.7 cells were seeded on hydroxyapatite 
disks, prepared as previously described (Matesanz et al., 2014), placed into each well of a 24-well culture 
plate, at a density of 1x10
4
 cells/cm
2 
in α-MEM without phenol red and supplemented with 4% FBS. In order 
to stimulate osteoclast differentiation, 40 ng/ml of mouse RANKL and 25 ng/ml M-CSF were added to the 
culture medium and cells were cultured for 14 days in the presence of MLO-Y4 cell-CM (20% in standard 
medium), renewing culture medium every 3 days, as previously reported (Torres-Rodríguez et al., 2016). 
Subsequently, cells were washed with PBS, harvested using PBS-EDTA for 10 min, and counted in a 
Neubauer hemocytometer for evaluating cell proliferation. Cell suspensions were then centrifuged at 310g 
for 10 min and resuspended in fresh medium for the analysis of cell viability. Cell viability was determined 
by propidium iodide (PI) exclusion and flow cytometry after addition of PI (0.005% in PBS, Sigma-Aldrich) 
to stain the DNA of dead cells.  
Morphological studies by confocal microscopy: RAW 264.7 cells grown on hydroxyapatite disks as 
described above for 14 d were fixed with 3.7% p-formaldehyde in PBS for 10 min, washed with PBS and 
permeabilized with 0.1% Triton X-100 for 3-5 min. The disks with permeabilized cells were then washed 
with PBS and pre-incubated with 1% BSA in PBS for 20-30 min. Thereafter, cells were incubated with 
rhodamine phalloidin (1:40, v/v, Molecular Probes, Eugene, OR, USA) for 20 min to stain F-actin filaments. 
Samples were then washed with PBS and the cell nuclei were stained with DAPI (4′-6-diamidino-2′-
phenylindole; Molecular Probes) at 3 µM in PBS. After staining and washing with PBS, cells were examined 
using a Leica SP2 confocal laser scanning microscope. Rhodamine fluorescence was excited at 540 nm and 
measured at 565 nm. DAPI fluorescence was excited at 405 nm and measured at 420–480 nm. The presence 
of multinucleated cells with F-actin rings was used as indicative of osteoclast-like cell differentiation. To 
evaluate the geometry of resorption cavities produced by osteoclast-like cells on the surface of 
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hydroxyapatite disks, cells were detached after 14 d of culture as described above, and subsequently, disks 
were dehydrated, coated with gold-palladium and examined with a JEOL JSM-6400 scanning electron 
microscope. 
Statistics: Data are expressed as mean ± standard deviation (SD) of at least 3 experiments carried out 
in triplicate. Statistical analysis was performed using GraphPad Prism (GraphPad software, La Jolla, CA, 
USA). Data were analyzed by Kruskal-Wallis test followed byDunn’s test. p<0.05 was considered 
significant.  
RESULTS 
It has been previously demonstrated that the same FF regime used here (10 dynes/cm2; 10 min) 
exerted a pro-survival effect onosteocyticMLO-Y4 cells, related to β-catenin stabilization and a nuclear ERK 
translocation (de Castro et al., 2015; Gortázar et al., 2013; Maycas et al., 2015). In the present study, we 
found that FF induced an increase in p-GSK3β, promoting the stabilization and nuclear increase of β-catenin 
(Fig 1A); and also induced ERK phosphorylation (p-ERK) and its translocation to the nucleus (Fig 1B). Pre-
exposure of MLO-Y4 cells to HG (25 mM) for 24 h inhibited both β-catenin and ERK nuclear translocation 
induced by FF; although HG did not alter the phosphorylation and subcellular localization of the proteins in 
SC conditions (Fig. 1A,B). Moreover, we found that this HG exposure –but not L-glucose as osmotic 
control- of MLO-Y4 cells increased apoptosis induced by etoposide, and reversed the protection induced by 
FF (Fig. 1C, left). Of note, the difference in osteocyte apoptosis between HG and NG was higher in FF than 
in SC condition (Fig. 1C, right).Similar findings with respect to protein phosphorylation andsubcellular 
localization, as well as cell death, were observed in pre-osteoblastic MC3T3-E1 cells (Fig. 2). 
We next analyzed the effect of HG and FF on the ability of both cell lines to interact with osteoclast 
precursors. For this purpose, MLO-Y4 and MC3T3-E1 cells were pre-exposed to either HG or normal 
glucose (NG) for 24 h, and cells were then subjected to FF or not (SC), followed by collecting the 
corresponding CM at 18h. We found that the CM from MLO-Y4 cells pre-exposed to HG inhibited RAW 
264.7 cell migration (Fig. 3A, left). This inhibition was of the same magnitude as that induced by the CM 
from FF-stimulated MLO-Y4 cells, independently of pre-exposure or not to HG (Fig. 3A, left). Similar 
results were obtained when RAW 264.7 cell migration was assessed using the wound healing assay (Fig. 3A, 
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right). In contrast, MC3T3-E1-cell CMs from any of these experimental conditions failed to significantly 
affect RAW 264.7 cell migration (Fig. 3B).The impact of HG and FF on the secretion of several chemokines 
by MLO-Y4 cells was next evaluated. Consistent with the aforementioned migration data, both FF and HG 
were found to inhibit the secreted levels of VEGF, RANTES, MIP-1a, MIP-1b, MCP-1 and GM-CSF (Fig. 
4). Of note, HG in fact potentiated the inhibitory effect of FF on the secretion of all these chemokines (Fig. 
4).   
We next assessed the effect of the different MLO-Y4 cell-CMs on the viability, proliferation and 
differentiation of osteoclast precursors after 14 d in osteoclast differentiation medium. First, we observed 
that none of these CMs tested significantly modified RAW 264.7 cell viability (Fig. 5A). On the other hand, 
the CM from SC cells pre-treated or not with HG (or L-glucose) inhibited RAW 264.7 cell proliferation; 
whereas the CM from MLO-Y4 cells subjected to FF highly stimulated proliferation, independently of HG 
pre-exposure or not (Fig. 5B). The effect of MLO-Y4 cell-CM on osteoclastogenesis was also analyzed in 
RAW 264.7 cells after 14 days of culture in the presence of RANKL and M-CSF by the identification of 
actin rings as a critical feature of mature osteoclasts. The CM from NG-SC osteocytic cells was able to 
induce osteoclast differentiation, inducing the formation of giant cells with actin rings and at least 3 nuclei, 
as observed by confocal microscopy (Fig.5C, upper panel).To evaluate the activity of these osteoclast-like 
cells, we seeded RAW 264.7 cells on hydroxyapatite disks for 14 d in the presence of RANKL/M-CSF and 
the different MLO-Y4 cell-CMs.CM from cells in SC conditions induced osteoclast activity, as detected by 
the geometry of resorption cavities produced by these cells whenexamined by SEM (Fig. 5C, lower panel, 
D). Interestingly, CM from MLO-Y4 cells pre-treated with HG allowed osteoclast-like cell formation but 
these cells showed minimal resorption activity on hydroxyapatite; whereas CM from FF-stimulated cells 
decreased osteoclast activity, even in the absence of HG (Fig. 5C, D). 
Consistent with these findings, RANKL and IL-6 secretion by MLO-Y4 cells were not affected by 
cell exposure to either HG (or L-glucose) in SC conditions; whereas FF stimulation, following HG pre-
exposure or not, decreased the secreted levels of both cytokines (Fig. 6).  
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DISCUSSION 
DM is a metabolic disease characterized by an inappropriate regulation of glucose metabolism 
affecting a variety of tissues including bone. At the cellular level, HG has been described to: inhibit 
proliferation and osteogenic differentiation of bone marrow mesenchymal cells; impair osteoblast 
mineralization; increase osteocyte and osteoblast apoptosis; and inhibit RANKL-induced osteoclastogenesis 
(Bouillon et al., 1995; Wittrant et al., 2008; Xu et al., 2015). In the present study, we further confirmed that 
HG prevented the protection conferred by mechanical stimulation by FF to osteoblastic lineage cells. 
Furthermore, we disclosed a differential impact of FF and HG on osteocyte-osteoclast communication. 
Both osteoblasts and osteocytes are able to detect and respond to mechanical and hormonal stimuli, 
but osteocytes -the main cell type in bone- uniquely coordinate the function of both osteoblasts and 
osteoclasts. Whereas mechanical loading was found to promote both osteoblast and osteocyte survival 
(present results and Bin et al, 2016; Maycas et al, 2016),only dying osteocytes (not osteoblasts) induce 
osteoclastogenesis (Kogianni et al, 2008).In this study, we aimed to explore the putative effect of HG on 
osteocyte-osteoclast communication, and we also used an osteoblastic cell line, MC3T3-E1 cells, to confirm 
the specificity of the observed effects of the CM from osteocytic MLO-Y4 cells on the migration of 
osteoclast precursors. As shown in fig 3, as expected, only the CM from osteocytic MLO-Y4 but not that 
from osteoblastic MC3T3-E1 cells modulated osteoclast precursor migration, confirming the important role 
of osteocytes in osteoclast function. 
A very recent study has shown that the anabolic effect induced by bone loading  was impaired in a 
T1D mouse model (Parajuli et al., 2015). These authors also showed that some of the beneficial effects 
induced by FF in MLO-Y4 cells, namely the inhibition of caspase 3/7 expression and induction of 
prostaglandin E2, were compromised by HG exposure. In the same line, we here found that cell survival, and 
two related mechanistic events -β-catenin and ERK nuclear translocation- induced by mechanical stimulation 
in MLO-Y4 cells were dramatically decreased by HG exposure. In the aforementioned study, HG exposure 
was also found to reverse the reduction of RANKL secretion induced by FF, in contrast to the present data. 
This difference between the two studies could be explained by the different pattern of treatments: whereas 
we exposed MLO-Y4 cells to HG for 24 h followed by 10 min FF, in the report by Parajuli et al.(2015), 
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MLO-Y4 cells were incubated with HG for 72 h prior to FF for 2 h. Indeed, the impact of HG on osteoblastic 
cells depends on time of exposure (Botolin et al, 2006; López-Herradón et al, 2013). In the present study, we 
observed that an acute exposure of MLO-Y4 cells to HG (24 h) prevented both ERK and β-catenin 
relocalization but only after mechanical stimulation by FF and not under SC conditions. Thus, this time of 
HG exposure does not seem to be sufficient to affect the basal levels of both proteins, although it might 
affect the formation of other components of the signalsome triggered by mechanotransduction leading to 
ERK and beta-catenin relocalization (Plotkin et al, 2005; Gortázar et al., 2013). In this regard,  α5-integrin, 
which is required for osteocyte mechanotransduction (Plotkin et al, 2005), has recently been shown to be 
reduced by HG in fibroblastic cells (Almeida et al, 2016). 
In the present study, the secretion of various chemokines, namely VEGF, RANTES, MIP-1α, MIP-
1β, MCP-1 and GM-CSF, was found to be inhibited following mechanical stimulation of MLO-Y4 cells by 
FF. This inhibitory effect was recapitulated -or even potentiated- by HG pre-exposure of these cells. 
Accordingly, RAW 264.7 cell migration in the presence of CM from these osteocytic cells after FF or HG 
treatment was also inhibited compared to that observed with the CM from the corresponding non-
mechanically stimulated cells.  
Inhibition of cell proliferation and arrest of cell cycle progression are required for osteoclast 
differentiation. RANKL has been reported to suppress proliferation of osteoclastic cells (Bharti et al., 2004) 
through induction of the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1 (Sankar et al., 2004). 
According to this notion, we found that exposure of RAW 264.7 cells to the MLO-Y4-cell CM inhibited 
their proliferation but allowed osteoclast-like cell formation, while the opposite occurred after exposure to 
the CM of FF-stimulated cells independently of the presence of HG. Consistently, this mechanical 
stimulation reduced the production of RANKL by these osteocytic cells, as shown here and previously by 
other investigators (Kim et al., 2006; Lau et al., 2010). In this sense, we also found that IL-6 secretion was 
inhibited by FF. This cytokine has been shown to promote bone resorption mainly by its ability to increase 
RANKL production in osteoblastic lineage cells (Palmqvist et al., 2002; Tamura et al., 1993). Moreover, IL-
6 is able to stimulate osteoclast formation in vitro, and IL-6 receptors have been identified in mature 
osteoclasts (Gao et al., 1998; Tamura et al., 1993). Furthermore, it isknown that mechanical stimulation of 
osteocytes induces the production of other factors that caninhibit osteoclast differentiation, such as nitric 
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oxide or the phosphoglycoprotein MEPE (Kulkarni et al., 2010; Tan et al., 2007). Our results also showed 
that FF or HG pre-treatment of MLO-Y4 cells had a different consequence on osteoclast function. Thus, in 
contrast to FF, HG pre-exposure failed to affect either RANKL or IL-6 secretion and allowed the formation 
of osteoclast multinucleated giant cells, although they were unable to resorb hydroxyapatite. The effect of 
DM on osteoclastogenesis and osteoclast activity in vivo is presently unclear (Bouillon et al., 1995; McCabe, 
2007; Tsentidis et al., 2015), but osteoclast precursor exposure to HG in vitro has been shown to directly 
inhibit the expression of two molecules, v-ATPase V0 subunit d2 and dendritic cell-specific transmembrane 
protein, which are key in the process of osteoclast fusion (Wittrant et al., 2008; Xu et al., 2015). Collectively, 
these data suggest that HG might directly and indirectly inhibit osteoclast function, affecting the formation of 
mature osteoclasts from osteoclast progenitors and also osteoclast activity by targeting osteocytes.  
The present findings are the first to our knowledge suggesting that HG affects osteocyte 
mechanotransduction to impact osteocyte-osteoclast communication, and open new avenues for 
understanding the mechanisms whereby DM can disturb bone metabolism.
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FIGURE LEGENDS 
 
Fig. 1. HG prevents the pro-survival effect of FF on osteocytic MLO-Y4cells. 
MLO-Y4 cells were exposed to normal glucose (NG), HG or L-glucose (25 mM) -osmotic control- for 24h 
before pulsatile (8 Hz) FF stimulation (10 dynes/cm
2
) for 10minwas carried out. Static control (SC) 
corresponds to non-mechanically stimulated cells. (A) p-GSK3β, total and nuclear β-catenin,and (B) total p-
ERK and nuclear ERK protein levels were evaluated by Western blotting in cell and nuclear extracts. 
Representative autoradiograms are shown. The dividing lines indicate different parts of the same gel 
(A).(C)MLO-Y4-nGFP cells were exposed to 50 µM etoposide after FF (or under SC) for 6 h, and 
subsequently apoptosis was assessed by enumerating nGFP-positive MLO-Y4 cells exhibiting chromatin 
condensation, and the percentage of apoptotic cells (left panel) or the Δ between percentage of apoptotic 
cells under HG and NG exposure (right panel), were shown. Apoptosis (mean ± SD) represented 3.6 ± 1.3 
%in etoposide-untreated cells. Values correspond to mean ± SD of at least 3 independent experiments in 
duplicate.*p<0.05; **p<0.01 vs NG-SC value; 
#
p<0.01 vs NG-FF value. 
Fig. 2.HG prevents the pro-survival effect of FF on osteoblasticMC3T3-E1 cells. 
MC3T3-E1 cells were exposed to NG, HG (25mM) or L-glucose for 24h before FF stimulation (10 
dynes/cm2) for 10min, or static control (SC). (A) p-GSK3β, β-catenin, and (B) p-ERK protein levels were 
evaluated by Western blotting in total protein extracts obtained immediately after the FF. (C) To evaluate 
cell death, MC3T3-E1 cells were exposed to 50 µM etoposide right after the FF or the SC, for 6 h, and 
subsequently trypan blue exclusion was determined. Values correspond to mean ± SD of 3 independent 
experiments in duplicate. *p<0.05; **p<0.01 vs NG SC value; #p<0.01 vs NG FF value.  
Fig. 3.HG or FF pre-treatment inhibited osteoclast precursor migration induced by the CM from MLO-
Y4cells but not from MC3T3-E1 cells. 
The conditioned medium (CM) from MLO-Y4 and MC3T3-E1 cells subjected or not (static control, SC) to 
FFfollowing pre-treatment with HG or normal glucose (NG) for 24 h,was collected 18 h thereafter, as 
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described in the text. (A, left and B) RAW 264.7 cell migration was assessed by exposing these cells to the 
different CMs [or to growth medium alone (Co)] for 6 h, using Costar transwellcell culture chamber inserts 
(8 μm pore size),or a wound healing assay (A, right), as described in the text. Representative images are 
shown in each case. Values correspond to mean ± SD of 3 independent experiments in triplicate. **p<0.01 
vsNG-SC-CM value. 
Fig. 4. Both HG and FF induce changes in chemokinesecretion by MLO-Y4 cells. 
MLO-Y4 cells were subjected or not (static control, SC) to FF following pre-treatment with HG or normal 
glucose (NG) for 24 h, and the cell-conditioned medium (CM) was collected 18h thereafterto determine the 
following chemokines by Luminex multiplex assay: VEGF, RANTES, MIP-1a, MIP-1b, MCP-1 and GM-
CSF. Values correspond to mean ± SD of 3 independent experiments in triplicate. *p<0.05 vs NG-SC value;
 
#
p<0.05 vs NG-FF value. 
Fig. 5. HG and FF pre-treatment differentially affect osteoclast precursor proliferation, differentiation and 
activity induced by theMLO-Y4 cell-conditioned medium. 
RAW 264.7 cells were exposed to the MLO-Y4 conditioned medium (CM) [or not (Co)] following HG 
exposure and/or FF stimulation, for 14 d, as described in the text. A) RAW 264.7 cell viability was 
determined by propidium iodide exclusion using flow cytometry, and (B)proliferation was assayed by flow 
cytometry as described in the text. Values correspond to mean ± SD of 3 independent experiments in 
triplicate. (C) RAW 264.7 cells were exposed to the different MLO-Y4 CMs supplemented with 40 ng/ml of 
RANKL and 25 ng/ml of M-CSFto stimulate osteoclast differentiation for 14 d. Osteoclast differentiation 
(upper panel) was observed by confocal microscopy (giant cells with actin ring and at least 3 nuclei) and 
osteoclast activity as formation of resorption lacunae detected by SEM (lower panel) was assessed by 
culturing RAW264.7 cells on hydroxyapatite disksin different experimental conditions for 14 d. Scale bars = 
20µm. (D)size of the resorption cavities in each experimental group was represented *p<0.01 vs Co value; 
**p<0.01 vs Co value.# p<0.01 vs NG-SC; ## p<0.05 NG-SC.  
Fig. 6. HG and FF differentially affect RANKL and IL-6 secretion in MLO-Y4 cells. 
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RANKL (A) and IL-6 (B) in the MLO-Y4-CMwere analyzed by ELISA as described in Materials and 
Methods. Values correspond to mean ± SD of 3 independent experiments in triplicate. *p<0.05; **<0.01vs 
all the other experimental conditionsin each case. 
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